Will there be an FDA Approved treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by 2030.
Health & MedicineOne-Off3y
Manifold MarketsNo KYCVerified resolution dataFairly calibratedCurrent community forecast
No 71.3%
Forecasters
5
Question type
binary
Methodology
Play-money forecasting platform
Source type
Forecast
Market data
Updated 2 hours ago
StaleJun 28, 24, 8:57 PM UTCJan 1, 30, 10:59 PM UTC
Trends
Related Markets
Related questions for context, not a comparison of equivalent contracts.
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
Manifold MarketsWill there be an FDA approved medication to lower lp(a) by the end of 2027?
Manifold MarketsWill Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2026?
Manifold MarketsBumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026?
FutuurWill the FDA approve a psilocybin treatment during 2026?
FutuurRaniPill microneedle pill to replace injections: approved for sale by the end of 2026?
FutuurRules
If the FDA approves a pharmaceutical intervention for ME/CFS before 1st Jan 2030 this market shall resolve to yes.
- This does not include potential comorbidities, such as long covid.
Open markets
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Total Vol
- $18.1M
- 24h Vol
- $22.1K
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Total Vol
- $1.9M
- 24h Vol
- $6K
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 more outcomes
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Total Vol
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Total Vol
- $1.1M
- 24h Vol
- $1.8K
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000-1.0pt96%
- Above 6000+1.0pt60%
+2 more outcomes
- Total Vol
- $1M
- 24h Vol
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
Frequently asked questions
- What are the current odds for Will there be an FDA Approved treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by 2030.?
- Manifold Markets prices No at 71% as of September 8, 2026.
- When does Will there be an FDA Approved treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by 2030. resolve?
- Will there be an FDA Approved treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by 2030. is scheduled to resolve on January 1, 2030.
- How is Will there be an FDA Approved treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by 2030. settled?
- Manifold Markets settles this market as follows: If the FDA approves a pharmaceutical intervention for ME/CFS before 1st Jan 2030 this market shall resolve to yes.